Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Atypical antipsychotics and glucose dysregulation: a systematic review.

Jin H, Meyer JM, Jeste DV.

Schizophr Res. 2004 Dec 1;71(2-3):195-212. Review.

PMID:
15474892
2.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
3.

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC.

J Clin Psychiatry. 2007 Apr;68(4):533-41.

PMID:
17474808
4.

A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.

Luft B, Taylor D.

Expert Opin Pharmacother. 2006 Sep;7(13):1739-48. Review.

PMID:
16925501
5.
6.

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.

Nasrallah HA, Newcomer JW.

J Clin Psychopharmacol. 2004 Oct;24(5 Suppl 1):S7-14.

PMID:
15356415
7.

Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Henderson DC.

Curr Diab Rep. 2002 Apr;2(2):135-40. Review.

PMID:
12643133
9.

New-onset diabetes and ketoacidosis with atypical antipsychotics.

Wilson DR, D'Souza L, Sarkar N, Newton M, Hammond C.

Schizophr Res. 2003 Jan 1;59(1):1-6.

PMID:
12413635
10.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
11.

Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Henderson DC.

CNS Drugs. 2002;16(2):77-89. Review.

PMID:
11825099
12.

Atypical antipsychotics and diabetes mellitus: an association.

Liberty IF, Todder D, Umansky R, Harman-Boehm I.

Isr Med Assoc J. 2004 May;6(5):276-9. Review.

13.

Factors in antipsychotic drug selection: tolerability considerations.

Nasrallah HA.

CNS Spectr. 2003 Nov;8(11 Suppl 2):23-5.

PMID:
14978455
14.

Hyperglycemia and antipsychotic medications.

Haupt DW, Newcomer JW.

J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.

PMID:
11806485
15.

A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.

Citrome L, Kalsekar I, Baker RA, Hebden T.

Curr Med Res Opin. 2014 Aug;30(8):1629-41. doi: 10.1185/03007995.2014.908280. Epub 2014 May 19. Review.

PMID:
24666104
16.

New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder.

Erickson SC, Le L, Zakharyan A, Stockl KM, Harada AS, Borson S, Ramsey SD, Curtis B.

J Am Geriatr Soc. 2012 Mar;60(3):474-9. doi: 10.1111/j.1532-5415.2011.03842.x. Epub 2012 Jan 30.

PMID:
22288652
17.
18.

Side effects of atypical antipsychotic drugs.

Ananth J, Parameswaran S, Gunatilake S.

Curr Pharm Des. 2004;10(18):2219-29. Review.

PMID:
15281897
19.

The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists.

Newcomer JW, Nasrallah HA, Loebel AD.

J Clin Psychopharmacol. 2004 Oct;24(5 Suppl 1):S1-6.

PMID:
15356414
20.

Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesity.

Heal DJ, Gosden J, Jackson HC, Cheetham SC, Smith SL.

Handb Exp Pharmacol. 2012;(212):135-64. doi: 10.1007/978-3-642-25761-2_6. Review.

PMID:
23129331

Supplemental Content

Support Center